- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01165918
Derivation of New Human Embryonic Stem Cell Lines: Identification of Instructive Factors for Germ Cells Development
July 18, 2010 updated by: Soroka University Medical Center
Basic Research. Unveiling Factors That Contribute to Germ Cell Differentiation
The purpose of this study is
- To generate human embryonic stem cells lines (hESC) lines
- Study of the factors that contribute to differentiation towards germ cell.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beer Sheva, Israel, 84101
- Soroka Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 days to 4 days (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
any donated embryo
Description
Inclusion Criteria:
- any donated embryos
Exclusion Criteria:
- not relevant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Donated embryos
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
New hESC
Time Frame: 1 year
|
Donated embryos will be used for derivation of the Es cells
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Factors that contribute to germ cells differentiation
Time Frame: 4 years
|
We shall employ the knowledge from a study of sperm differentiation in mice to instruct the differentiation of ES cells towards germ cells
|
4 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Study Registration Dates
First Submitted
July 6, 2010
First Submitted That Met QC Criteria
July 18, 2010
First Posted (Estimate)
July 20, 2010
Study Record Updates
Last Update Posted (Estimate)
July 20, 2010
Last Update Submitted That Met QC Criteria
July 18, 2010
Last Verified
June 1, 2010
More Information
Terms related to this study
Other Study ID Numbers
- Sor491210CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal Healthy Embryos
-
Sophie DebrockCompletedCryopreservation of EmbryosBelgium
-
University Hospital, GasthuisbergCompleted
-
PfizerCompletedNormal HealthyUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedNormal, Healthy VolunteersAustralia
-
Halia Therapeutics, Inc.TKL Research, Inc.Completed
-
USWM, LLC (dba US WorldMeds)National Institute on Drug Abuse (NIDA)Completed
-
Bausch Health Americas, Inc.Completed
-
USWM, LLC (dba US WorldMeds)National Institute on Drug Abuse (NIDA)Completed